Literature DB >> 27281730

Adverse Drug Effects and Preoperative Medication Factors Related to Perioperative Low-Dose Ketamine Infusions.

Eric S Schwenk1, Stephen F Goldberg, Ronak D Patel, Jon Zhou, Douglas R Adams, Jaime L Baratta, Eugene R Viscusi, Richard H Epstein.   

Abstract

High-dose opioid administration is associated with significant adverse events. Evidence suggests that low-dose ketamine infusions improve perioperative analgesia over conventional opioid management, but usage is highly variable. Ketamine's adverse drug effects (ADEs) are well known, but their prevalence during low-dose infusions in a clinical setting and how often they lead to infusion discontinuation are unknown. The purposes of this study were 3-fold: (1) to identify patient factors associated with initiation of ketamine infusions during spine surgery, (2) to identify specific spine procedures in which ketamine has been used most frequently, and (3) to identify ADEs associated with postoperative ketamine infusions and which ADEs most frequently led to discontinuation. Spine surgery was chosen because of its association with moderate to severe pain and a relatively high use of ketamine infusions in this population at our hospital.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27281730     DOI: 10.1097/AAP.0000000000000416

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  7 in total

Review 1.  Ketamine Use in the Surgical Patient: a Literature Review.

Authors:  Tiffany S Moon; Katelynn M Smith
Journal:  Curr Pain Headache Rep       Date:  2021-02-25

Review 2.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

3.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Eric S Schwenk; Eugene R Viscusi; Asokumar Buvanendran; Robert W Hurley; Ajay D Wasan; Samer Narouze; Anuj Bhatia; Fred N Davis; William M Hooten; Steven P Cohen
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

4.  Evaluation of Clinical Factors Associated with Adverse Drug Events in Patients Receiving Sub-Anesthetic Ketamine Infusions.

Authors:  Alexander D Stoker; David M Rosenfeld; Matthew R Buras; Jeremy M Alvord; Andrew W Gorlin
Journal:  J Pain Res       Date:  2019-12-23       Impact factor: 3.133

5.  Adverse Effects Associated with Patient-Controlled Analgesia with Ketamine Combined with Opioids and Ketamine Infusion with PCA Bolus in Postoperative Spine Patients: A Retrospective Review.

Authors:  Tiffany M Pouldar; Dermot P Maher; Alexander W Betz; Jeffrey J Wiegers; Jeremy A Friedman; Sameer S Zaidi; Ali Rejali; Hai P Tran; Roya Yumul; Charles Louy
Journal:  J Pain Res       Date:  2022-10-10       Impact factor: 2.832

Review 6.  Can Intraoperative Low-Dose R,S-Ketamine Prevent Depressive Symptoms After Surgery? The First Meta-Analysis of Clinical Trials.

Authors:  Liwei Pang; Meiying Cui; Wanling Dai; Jing Kong; Hongzhi Chen; Shuodong Wu
Journal:  Front Pharmacol       Date:  2020-10-19       Impact factor: 5.810

7.  Low-Dose Ketamine Infusion for Perioperative Pain Management in Patients Undergoing Laparoscopic Gastric Bypass: A Prospective Randomized Controlled Trial.

Authors:  Mitchell T Seman; Shawn H Malan; Matthew R Buras; Richard J Butterfield; Kristi L Harold; James A Madura; David M Rosenfeld; Andrew W Gorlin
Journal:  Anesthesiol Res Pract       Date:  2021-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.